
|Articles|October 15, 2002
Injecting botulinum toxin A in frontalis may result in ptosis
New York-Eyelid ptosis following botulinum toxin A (Botox, Allergan) therapy is directly related to using frontalis injection, though other investigators have not linked the characteristic droopiness to that approach, said Michael Kane, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
PolyActiva and RareSight partner to develop treatments for rare pediatric retinal diseases
2
Kodiak Sciences releases follow-up, 20-week data from APEX study
3
From then to next: Five decades of transformation in ophthalmology
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


